Pfizer and BioNTech have submitted their application to the US Food and Drug Administration for emergency use authorization of their bivalent Covid-19 vaccine for use in people age 12 and older, the companies said in a statement on Monday.

(SOURCE) https://www.cnn.com/2022/08/22/health/pfizer-covid-omicron-booster-submission/index.html